Answers are grounded in this paper and cite their sources.
to confidently predict which young adult smokers will develop clinically important COPD. Meanwhile, we do not think that assembling a panel of clinicians to attempt a consensus about the diagnosis of COPD in a number of cases will be useful. Establishing a diagnosis is a means to an end: intervention. Apart from smoking cessation, which is effective at any level of FEV1, the cost-effectiveness of COPD interventions when FEV1 is .60% pred remains very poor, and, thus, screening or case-finding for early COPD should not currently be performed [6]. We are especially concerned for older persons who are classified as having COPD stage I, as such a designation may lead to inappropriate pharmacotherapy and delays in the consideration of other diagnoses, such as heart failure, which is common in older smokers [7].
No takes yet. Share an insight, caveat, or question.
Vestbo et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: